Insights from an interview of Jyoti Singh – Senior Principal Consultant with Dr. Sam Roberts, Chief Executive of NICE, focusing on NICE’s evolving role under the NHS 10-Year Plan. 

It highlights national strategic priorities, regulatory collaborations, funding challenges, and tailored advice for NHS, industry and Medtech stakeholders. 

1. What is changing at NICE following the release of the 10-year plan?

2. How will NICE coordinate with MHRA, NHS England, DHSC, and ICBs to avoid delays in patients accessing medicines?
 

3. How is NICE supporting local engagement adoption?
 

4. Funding challenges – how is NICE supporting to address them?
 

5. How are high-cost therapies managed nationally?
 

6. What is NICE’s position on the Single National Formulary?
 

7. What’s happening with the severity modifier?
 

8. What is NICE doing to support pharma companies amid VPAG concerns?
 

9. What advice does NICE offer to pharma companies?
 

10.  Progress on commissioning of new technology 
 

11. What advice does NICE offer to MedTech companies?